Clinical Trial Update: Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update estimating the risk of Plasmodium vivax relapses in Afghanistan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vivax Malaria

Snippet

Sponsor: University of Oxford | Conditions: Vivax Malaria | Phase 4 | Status: COMPLETED